Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
#859176
ClinicalTrials.gov
Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
#861612
ClinicalTrials.gov
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
#863154
ClinicalTrials.gov
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
#865065
ClinicalTrials.gov
A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
#874585
ClinicalTrials.gov
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
#877567
ClinicalTrials.gov
A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
#889937
ClinicalTrials.gov
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma
#895610
ClinicalTrials.gov
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
#900554
ClinicalTrials.gov
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT
#903158
ClinicalTrials.gov
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
#900530
ClinicalTrials.gov
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
#230398
ClinicalTrials.gov
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
#803632
ClinicalTrials.gov
Redirected Auto T Cells for Advanced Myeloma
#884127
ClinicalTrials.gov
Autophagy Induction After Bortezomib for Myeloma
#888737
ClinicalTrials.gov
Myeloma Treatment in Real Life
#967500
ClinicalTrials.gov
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
#980608
ClinicalTrials.gov
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
#878145
ClinicalTrials.gov
A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
#405137
ClinicalTrials.gov
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
#435723
ClinicalTrials.gov
A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma
#833373
ClinicalTrials.gov
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
#842878
ClinicalTrials.gov
A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma
#861427
ClinicalTrials.gov
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
#875446
ClinicalTrials.gov
APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma
#880781
ClinicalTrials.gov
Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma
#883909
ClinicalTrials.gov
Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
#885456
ClinicalTrials.gov
CART-19 for Multiple Myeloma
#896745
ClinicalTrials.gov
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
#898441
ClinicalTrials.gov
Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)
#903858
ClinicalTrials.gov
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
#906380
ClinicalTrials.gov
Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma
#907091
ClinicalTrials.gov
A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation
#907499
ClinicalTrials.gov
Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).
#915741
ClinicalTrials.gov
A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma
#979704
ClinicalTrials.gov
Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)
#982719
ClinicalTrials.gov
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma
#832071
ClinicalTrials.gov
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
#854150
ClinicalTrials.gov
Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
#806765
ClinicalTrials.gov
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
#845559
ClinicalTrials.gov
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
#855770
ClinicalTrials.gov
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
#862515
ClinicalTrials.gov
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
#377425
ClinicalTrials.gov
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
#407719
ClinicalTrials.gov
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
#801682
ClinicalTrials.gov
Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
#847280
ClinicalTrials.gov
Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
#910346
ClinicalTrials.gov
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
#968919
ClinicalTrials.gov
A Study of Daratumumab
#804797
ClinicalTrials.gov
Discontinuation Study
#868943
ClinicalTrials.gov
← Previous
Page 10 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.